Skip to main content
See every side of every news story
Published loading...Updated

“Obesity Management Is a Long-Term Battle”… Why Hanmi Pharmaceutical Is Combining ‘EFE’ with Digital Technology

Summary by 조선일보
Hanmi Pharmaceutical is integrating digital technology into its new obesity drug, 'Effe.' The system allows patients to record their weight loss, diet, exercise, and the frequency of side effects via a smartphone app after receiving a prescription. Doctors can then analyze these records to formulate appropriate treatment strategies for the patient. Through this approach, Hanmi Pharmaceutical plans to improve patients' lifestyle habits as well. ◇…

1 Articles

Lean Right

Hanmi Pharmaceutical is integrating digital technology into its new obesity drug, 'Effe.' The system allows patients to record their weight loss, diet, exercise, and the frequency of side effects via a smartphone app after receiving a prescription. Doctors can then analyze these records to formulate appropriate treatment strategies for the patient. Through this approach, Hanmi Pharmaceutical plans to improve patients' lifestyle habits as well. ◇…

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

조선일보 broke the news on Saturday, September 5, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal